8/17/2009

Researchers at the Center for Stem Cell and Regenerative Medicine in Cleveland have undertaken 51 clinical trials involving adult stem cells and other cell treatments since its inception in 2003. The CSCRM also has launched four stem cell startups, which together with a biopharmaceutical firm raised more than $235 million in venture capital and grant funding since 2003. Experts said these milestones, together with Cleveland's rich background in adult stem cell research, place the city on par with Boston and California.

Related Summaries